Judice Kevin 4
4 · DICE Therapeutics, Inc. · Filed Jan 31, 2023
Insider Transaction Report
Form 4
Judice Kevin
DirectorCEO
Transactions
- Award
Stock Option (right to buy)
2023-01-27+300,000→ 300,000 totalExercise: $32.31Exp: 2033-01-26→ Common Stock (300,000 underlying) - Award
Restricted Stock Unit (RSU)
2023-01-27+50,000→ 50,000 total→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]The option vests as to 1/48th of the total shares monthly, beginning January 27, 2023, until such time as the option is 100% vested on the four-year anniversary, subject to the Reporting Holder's continued service to the Registrant.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.
- [F3]The RSUs vest as to 1/4th of the total shares annually, beginning January 27, 2023, until such time as the RSUs are 100% vested on the four-year anniversary, subject to the Reporting Holder's continued service to the Registrant.